The eIF2α kinase heme-regulated inhibitor protects the host from infection by regulating intracellular pathogen trafficking

Wael Bahnan, Justin C. Boucher, Petoria Gayle, Niraj Shrestha, Mark Rosen, Bertal Aktas, Rebecca D Adkins, Arba L Ager, Wasif Khan, Kurt Schesser

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The host employs both cell-autonomous and system-level responses to limit pathogen replication in the initial stages of infection. Previously, we reported that the eukaryotic initiation factor 2α (eIF2α) kinases heme-regulated inhibitor (HRI) and protein kinase R (PKR) control distinct cellular and immune-related activities in response to diverse bacterial pathogens. Specifically for Listeria monocytogenes, there was reduced translocation of the pathogen to the cytosolic compartment in HRIdeficient cells and consequently reduced loading of pathogen-derived antigens on major histocompatibility complex class I (MHC-I) complexes. Here we show that Hri-/- mice, as well as wild-type mice treated with an HRI inhibitor, are more susceptible to listeriosis. In the first few hours of L. monocytogenes infection, there was much greater pathogen proliferation in the liver of Hri-/- mice than in the liver of Hri+/+ mice. Further, there was a rapid increase of serum interleukin-6 (IL-6) levels in Hri+/+ mice in the first few hours of infection whereas the increase in IL-6 levels in Hri-/- mice was notably delayed. Consistent with these in vivo findings, the rate of listeriolysin O (LLO)-dependent pathogen efflux from infected Hri-/- macrophages and fibroblasts was significantly higher than the rate seen with infected Hri+/+ cells. Treatment of cells with an eIF2α kinase activator enhanced both the HRI-dependent and PKR-dependent infection phenotypes, further indicating the pharmacologically malleability of this signaling pathway. Collectively, these results suggest that HRI mediates the cellular confinement and killing of virulent L. monocytogenes in addition to promoting a system-level cytokine response and that both are required to limit pathogen replication during the first few hours of infection.

Original languageEnglish (US)
Article numbere00707-17
JournalInfection and Immunity
Volume86
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Eukaryotic Initiation Factor-2
Heme
Phosphotransferases
Listeria monocytogenes
Infection
Listeriosis
Protein Kinase Inhibitors
Interleukin-6
Liver
Major Histocompatibility Complex
Fibroblasts
Macrophages
Cytokines
Phenotype
Antigens
Serum

Keywords

  • EIF2α kinase
  • Heme-regulated inhibitor
  • HRI
  • Listeria monocytogenes
  • Macrophages
  • Microbial pathogenesis
  • Stress response

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Infectious Diseases

Cite this

The eIF2α kinase heme-regulated inhibitor protects the host from infection by regulating intracellular pathogen trafficking. / Bahnan, Wael; Boucher, Justin C.; Gayle, Petoria; Shrestha, Niraj; Rosen, Mark; Aktas, Bertal; Adkins, Rebecca D; Ager, Arba L; Khan, Wasif; Schesser, Kurt.

In: Infection and Immunity, Vol. 86, No. 3, e00707-17, 01.03.2018.

Research output: Contribution to journalArticle

Bahnan, Wael ; Boucher, Justin C. ; Gayle, Petoria ; Shrestha, Niraj ; Rosen, Mark ; Aktas, Bertal ; Adkins, Rebecca D ; Ager, Arba L ; Khan, Wasif ; Schesser, Kurt. / The eIF2α kinase heme-regulated inhibitor protects the host from infection by regulating intracellular pathogen trafficking. In: Infection and Immunity. 2018 ; Vol. 86, No. 3.
@article{247a65f1e14c49fc951b7882f7496846,
title = "The eIF2α kinase heme-regulated inhibitor protects the host from infection by regulating intracellular pathogen trafficking",
abstract = "The host employs both cell-autonomous and system-level responses to limit pathogen replication in the initial stages of infection. Previously, we reported that the eukaryotic initiation factor 2α (eIF2α) kinases heme-regulated inhibitor (HRI) and protein kinase R (PKR) control distinct cellular and immune-related activities in response to diverse bacterial pathogens. Specifically for Listeria monocytogenes, there was reduced translocation of the pathogen to the cytosolic compartment in HRIdeficient cells and consequently reduced loading of pathogen-derived antigens on major histocompatibility complex class I (MHC-I) complexes. Here we show that Hri-/- mice, as well as wild-type mice treated with an HRI inhibitor, are more susceptible to listeriosis. In the first few hours of L. monocytogenes infection, there was much greater pathogen proliferation in the liver of Hri-/- mice than in the liver of Hri+/+ mice. Further, there was a rapid increase of serum interleukin-6 (IL-6) levels in Hri+/+ mice in the first few hours of infection whereas the increase in IL-6 levels in Hri-/- mice was notably delayed. Consistent with these in vivo findings, the rate of listeriolysin O (LLO)-dependent pathogen efflux from infected Hri-/- macrophages and fibroblasts was significantly higher than the rate seen with infected Hri+/+ cells. Treatment of cells with an eIF2α kinase activator enhanced both the HRI-dependent and PKR-dependent infection phenotypes, further indicating the pharmacologically malleability of this signaling pathway. Collectively, these results suggest that HRI mediates the cellular confinement and killing of virulent L. monocytogenes in addition to promoting a system-level cytokine response and that both are required to limit pathogen replication during the first few hours of infection.",
keywords = "EIF2α kinase, Heme-regulated inhibitor, HRI, Listeria monocytogenes, Macrophages, Microbial pathogenesis, Stress response",
author = "Wael Bahnan and Boucher, {Justin C.} and Petoria Gayle and Niraj Shrestha and Mark Rosen and Bertal Aktas and Adkins, {Rebecca D} and Ager, {Arba L} and Wasif Khan and Kurt Schesser",
year = "2018",
month = "3",
day = "1",
doi = "10.1128/IAI.00707-17",
language = "English (US)",
volume = "86",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - The eIF2α kinase heme-regulated inhibitor protects the host from infection by regulating intracellular pathogen trafficking

AU - Bahnan, Wael

AU - Boucher, Justin C.

AU - Gayle, Petoria

AU - Shrestha, Niraj

AU - Rosen, Mark

AU - Aktas, Bertal

AU - Adkins, Rebecca D

AU - Ager, Arba L

AU - Khan, Wasif

AU - Schesser, Kurt

PY - 2018/3/1

Y1 - 2018/3/1

N2 - The host employs both cell-autonomous and system-level responses to limit pathogen replication in the initial stages of infection. Previously, we reported that the eukaryotic initiation factor 2α (eIF2α) kinases heme-regulated inhibitor (HRI) and protein kinase R (PKR) control distinct cellular and immune-related activities in response to diverse bacterial pathogens. Specifically for Listeria monocytogenes, there was reduced translocation of the pathogen to the cytosolic compartment in HRIdeficient cells and consequently reduced loading of pathogen-derived antigens on major histocompatibility complex class I (MHC-I) complexes. Here we show that Hri-/- mice, as well as wild-type mice treated with an HRI inhibitor, are more susceptible to listeriosis. In the first few hours of L. monocytogenes infection, there was much greater pathogen proliferation in the liver of Hri-/- mice than in the liver of Hri+/+ mice. Further, there was a rapid increase of serum interleukin-6 (IL-6) levels in Hri+/+ mice in the first few hours of infection whereas the increase in IL-6 levels in Hri-/- mice was notably delayed. Consistent with these in vivo findings, the rate of listeriolysin O (LLO)-dependent pathogen efflux from infected Hri-/- macrophages and fibroblasts was significantly higher than the rate seen with infected Hri+/+ cells. Treatment of cells with an eIF2α kinase activator enhanced both the HRI-dependent and PKR-dependent infection phenotypes, further indicating the pharmacologically malleability of this signaling pathway. Collectively, these results suggest that HRI mediates the cellular confinement and killing of virulent L. monocytogenes in addition to promoting a system-level cytokine response and that both are required to limit pathogen replication during the first few hours of infection.

AB - The host employs both cell-autonomous and system-level responses to limit pathogen replication in the initial stages of infection. Previously, we reported that the eukaryotic initiation factor 2α (eIF2α) kinases heme-regulated inhibitor (HRI) and protein kinase R (PKR) control distinct cellular and immune-related activities in response to diverse bacterial pathogens. Specifically for Listeria monocytogenes, there was reduced translocation of the pathogen to the cytosolic compartment in HRIdeficient cells and consequently reduced loading of pathogen-derived antigens on major histocompatibility complex class I (MHC-I) complexes. Here we show that Hri-/- mice, as well as wild-type mice treated with an HRI inhibitor, are more susceptible to listeriosis. In the first few hours of L. monocytogenes infection, there was much greater pathogen proliferation in the liver of Hri-/- mice than in the liver of Hri+/+ mice. Further, there was a rapid increase of serum interleukin-6 (IL-6) levels in Hri+/+ mice in the first few hours of infection whereas the increase in IL-6 levels in Hri-/- mice was notably delayed. Consistent with these in vivo findings, the rate of listeriolysin O (LLO)-dependent pathogen efflux from infected Hri-/- macrophages and fibroblasts was significantly higher than the rate seen with infected Hri+/+ cells. Treatment of cells with an eIF2α kinase activator enhanced both the HRI-dependent and PKR-dependent infection phenotypes, further indicating the pharmacologically malleability of this signaling pathway. Collectively, these results suggest that HRI mediates the cellular confinement and killing of virulent L. monocytogenes in addition to promoting a system-level cytokine response and that both are required to limit pathogen replication during the first few hours of infection.

KW - EIF2α kinase

KW - Heme-regulated inhibitor

KW - HRI

KW - Listeria monocytogenes

KW - Macrophages

KW - Microbial pathogenesis

KW - Stress response

UR - http://www.scopus.com/inward/record.url?scp=85042300494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042300494&partnerID=8YFLogxK

U2 - 10.1128/IAI.00707-17

DO - 10.1128/IAI.00707-17

M3 - Article

VL - 86

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 3

M1 - e00707-17

ER -